Study |
Country |
Sample size (n) |
Study design |
Mean age (years) |
Adverse outcomes |
Pre-existing CVD* and HTN |
Huang et al., 2020 |
China |
41 |
Prospective single-center |
49 |
ICU admission |
Pre-existing CVD (afibrillation) and HTN |
Guan et al., 2020 |
China |
1099 |
Retrospective multi-center |
47 |
ICU admission/mechanical ventilation/death |
Pre-existing CVD and HTN |
Zheng et al., 2020 |
China |
34 |
Retrospective single-center |
66 |
Invasive mechanical ventilation |
Pre-existing CVD and HTN |
Wang et al., 2020 |
China |
138 |
Retrospective single-center |
56 |
ICU admission |
Pre-existing CVD and HTN |
Chen et al., 2020 |
China |
21 |
Retrospective single-center |
56 |
Severe diseasea
|
HTN |
Hong et al., 2020 |
South Korea |
98 |
Retrospective single-center |
55 |
ICU admission |
Pre-existing CVD and HTN |
Wang et al., 2020 |
China |
69 |
Retrospective single-center |
42 |
SpO2<90% |
Pre-existing CVD and HTN |
Mo et al., 2020 |
China |
155 |
Retrospective single-center |
54 |
Refractory pneumonia |
Pre-existing CVD and HTN |
Wu et al., 2020 |
China |
201 |
Retrospective single-center |
51 |
ARDS |
Pre-existing CVD and HTN |
Zhou et al., 2020 |
China |
191 |
Retrospective multi-center |
56 |
Death |
Pre-existing CVD and HTN |
Wang et al., 2020 |
China |
339 |
Retrospective single-center |
69 |
Death |
Pre-existing CVD and HTN |
Huang et al., 2020 |
China |
202 |
Retrospective multi-center |
44 |
Severe diseasea
|
Pre-existing CVD and HTN |
Colaneri et al., 2020 |
Italy |
44 |
Retrospective single-center |
67 |
Severe diseasea
|
Pre-existing CVD and HTN |
Goyal et al., 2020 |
USA |
393 |
Retrospective multi-center |
62.2 |
Invasive mechanical ventilation |
Pre-existing CVD and HTN |
Ruan et al., 2020 |
China |
150 |
Retrospective multi-center |
58.5 |
Death |
Pre-existing CVD and HTN |
Du R et al., 2020 |
China |
179 |
Prospective single-center |
57.6 |
Death |
Pre-existing CVD and HTN |
Qin et al., 2020 |
China |
452 |
Retrospective single-center |
58 |
Severe diseasea
|
Pre-existing CVD and HTN |
Paranjpe et al., 2020 |
USA |
2199 |
Retrospective single-center |
65 |
Death |
Pre-existing CVD and HTN |
Zheng et al., 2020 |
China |
161 |
Retrospective single-center |
45 |
Severe diseasea
|
Pre-existing CVD and HTN |
Zhang et al., 2020 |
China |
663 |
Retrospective single-center |
55.6 |
Death |
Pre-existing CVD and HTN |
Mikami et al., 2020 |
USA |
6493 |
Retrospective multi-center |
59 |
Death |
HTN |
Marcello et al., 2020 |
USA |
13442 |
Retrospective multi-center |
52.7 |
Death |
Pre-existing CVD and HTN |
Wang et al., 2020 |
China |
275 |
Retrospective single-center |
49 |
Severe diseasea
|
Pre-existing CVD and HTN |
Cao et al., 2020 |
China |
80 |
Retrospective single-center |
53 |
Severe diseasea
|
Pre-existing CVD and HTN |
Shahriarirad et al., 2020 |
Iran |
113 |
Retrospective multi-center |
53.75 |
Severe diseasea
|
Pre-existing CVD and HTN |
Suleyman et al., 2020 |
USA |
463 |
Prospective multi-center |
57.5 |
ICU admission |
Pre-existing CVD and HTN |
Khamis et al., 2020 |
Oman |
63 |
Retrospective multi-center |
48 |
ICU admission |
Pre-existing CVD and HTN |
Zhang et al., 2020 |
China |
140 |
Retrospective single-center |
57 |
Severe diseasea
|
Pre-existing CVD and HTN |
Yang et al., 2020 |
China |
52 |
Retrospective single-center |
59.7 |
Death |
Pre-existing CVD |
Total studies = 29 |
|
Total, n=27,950 |
|
|
|
|